Company overview
Standard BioTools provides precision genomic and proteomic solutions, including high-throughput instruments like Biomark X9 for PCR, genotyping, and NGS library prep, alongside CyTOF for mass cytometry and Hyperion for tissue imaging. Their multi-omic lab services support biomarker discovery, drug development, clinical trials, and pathogen detection by turning samples into high-quality data. Scalable microfluidics technology enables up to 9,216 reactions per run with reduced contamination risk and enhanced workflow efficiency.
Standard BioTools is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include standard biotools, mass cytometry, high-throughput genomics, somascan proteomics, multi-omic services, biomarker discovery.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://standardbio.com
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- standard biotools, mass cytometry, high-throughput genomics, somascan proteomics, multi-omic services, biomarker discovery
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What technologies does Standard BioTools offer for genomics and proteomics?
- Core technologies include Biomark for high-throughput genomics (PCR, genotyping, NGS), CyTOF for single-cell proteomics, Hyperion for spatial proteomics, and SomaScan with KREX for high-plex autoantibody profiling.
- What lab services are available for pharma R&D?
- Expert-run multi-omic services cover mass cytometry, tissue imaging, custom conjugation, and SomaScan/KREX for biomarker discovery, drug development, clinical trials, immune response, and pathogen detection.
- How does Standard BioTools support scalability in research?
- Microfluidic integrated fluidic circuits (IFCs) with Nanoflex valves enable scalable assays up to 9,216 reactions per run, minimizing pipetting, contamination, and sample use compared to 96-well plates.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
